The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure.

Giraudo, C; Guarnieri, G; Molena, B; Caminati, M; Stramare, R; Vianello, A

Giraudo, C; Guarnieri, G; Molena, B; Caminati, M; Stramare, R; Vianello, A.

Giraudo C; Department of Medicine DIMED, University of Padova, Padova, Italy.
Guarnieri G; Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
Molena B; Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
Caminati M; Department of Medicine, University of Verona.
Stramare R; Department of Medicine DIMED, University of Padova, Padova, Italy.
Vianello A; Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy. Electronic address: andrea.vianello@aopd.veneto.it.

Pulmonology ; 2022 Jul 22.

Article in English | MEDLINE | ID: covidwho-1956307

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: J.pulmoe.2022.07.003

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google